BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32970929)

  • 21. Rational design of cancer gene panels with OncoPaD.
    Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
    Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes and their role in tumorigenesis and anticancer drug resistance.
    Milman N; Ginini L; Gil Z
    Drug Resist Updat; 2019 Jul; 45():1-12. PubMed ID: 31369918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
    Qu X; Sheng J; Shen L; Su J; Xu Y; Xie Q; Wu Y; Zhang X; Sun L
    PLoS One; 2017; 12(3):e0173712. PubMed ID: 28301876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.
    Yuan S; Liu Z; Xu Z; Liu J; Zhang J
    J Hematol Oncol; 2020 Jul; 13(1):91. PubMed ID: 32660524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X; Qi Z; Yin H; Yang G
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.
    Wang J; Garbutt C; Ma H; Gao P; Hornicek FJ; Kan Q; Shi H; Duan Z
    Gynecol Oncol; 2018 Jul; 150(1):143-150. PubMed ID: 29699801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards the overcoming of anticancer drug resistance mediated by p53 mutations.
    Cao X; Hou J; An Q; Assaraf YG; Wang X
    Drug Resist Updat; 2020 Mar; 49():100671. PubMed ID: 31841768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.
    Peng Y; Miao H; Wu S; Yang W; Zhang Y; Xie G; Xie X; Li J; Shi C; Ye L; Sun W; Wang L; Liang H; Ou J
    Autophagy; 2016 Nov; 12(11):2167-2182. PubMed ID: 27559856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.
    Rostami N; Nikkhoo A; Ajjoolabady A; Azizi G; Hojjat-Farsangi M; Ghalamfarsa G; Yousefi B; Yousefi M; Jadidi-Niaragh F
    Mol Diagn Ther; 2019 Aug; 23(4):467-487. PubMed ID: 31115798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of interplay between autophagy and metabolism in cancer.
    Raj S; Chandel V; Kumar A; Kesari KK; Asthana S; Ruokolainen J; Kamal MA; Kumar D
    Life Sci; 2020 Oct; 259():118184. PubMed ID: 32763290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 affects the resistance and stemness of SKOV3-derived ovarian cancer stem cells by regulating autophagy.
    You Y; Bi FF; Jiang Y; Xu YT; An YY; Li D; Yang Q
    Cancer Med; 2019 Feb; 8(2):656-668. PubMed ID: 30636383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Cancer-associated Fibroblasts in Tumorigenesis of Gastric Cancer.
    Ma Z; Chen M; Yang X; Xu B; Song Z; Zhou B; Yang T
    Curr Pharm Des; 2018; 24(28):3297-3302. PubMed ID: 29852862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer.
    Zhou F; Yang X; Zhao H; Liu Y; Feng Y; An R; Lv X; Li J; Chen B
    Theranostics; 2018; 8(19):5200-5212. PubMed ID: 30555541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.